BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21903243)

  • 1. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
    Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
    Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
    Thomas AZ; Adibi M; Borregales LD; Hoang LN; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2015 Aug; 194(2):316-22. PubMed ID: 25758610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.
    Choi C; Kang M; Seo SI; Suh J; Song C; Chung J; Kim SH; Park JY; Hwang EC; Jeong CW; Kwak C; Kim JK; Hong SH
    J Korean Med Sci; 2024 Jan; 39(3):e11. PubMed ID: 38258358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups.
    Karam JA; Bhattacharya R; Ogbomo A; Gautam S; Yu R; Sundaram M; Imai K; Chhabra J; Haas NB
    Cancer Med; 2024 Jun; 13(11):e7247. PubMed ID: 38826126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up.
    Barnoiu OS; Johannesen TB; Diep LM; Pedersen ES; Hjelle KM; Beisland C
    Scand J Urol; 2024 Jan; 59():1-9. PubMed ID: 38226773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma.
    Malleo G; Salvia R; Maggino L; Marchegiani G; D'Angelica M; DeMatteo R; Kingham P; Pulvirenti A; Sereni E; Jarnagin WR; Bassi C; Allen PJ; Butturini G
    Ann Surg Oncol; 2021 Jun; 28(6):3100-3108. PubMed ID: 33575870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis.
    Hakimi K; Saidian A; Panian J; Barata P; Berg S; Chang SL; Saliby RM; Dzimitrowicz H; Emamekhoo H; Gross E; Kilari D; Lam E; Nguyen M; Meagher M; Wang L; Rauterkus GP; D'Andrea V; Yim K; Psutka S; Thapa B; Weise N; Zhang T; McKay RR; Derweesh IH
    Clin Genitourin Cancer; 2023 Dec; 21(6):694-702. PubMed ID: 37558529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J; Bai J; Pan H; Zhou Z
    Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patients post-surgical resection A single-center, retrospective study.
    Taneja S; Bonert M; Hoogenes J; Matsumoto K; Shayegan B; Matsumoto ED; Lambe S; Piercey K; Kapoor A
    Can Urol Assoc J; 2024 Mar; 18(3):E53-E58. PubMed ID: 37931279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent renal cell cancer: 10 years or more after nephrectomy.
    Abara E; Chivulescu I; Clerk N; Cano P; Goth A
    Can Urol Assoc J; 2010 Apr; 4(2):E45-9. PubMed ID: 20368882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent distant metastasis of renal cell carcinoma to skin: A case report.
    Singh P; Somani K
    Clin Case Rep; 2020 Jul; 8(7):1138-1141. PubMed ID: 32695344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
    Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
    BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma.
    Fei C; Zhen X; Shiqiang Z; Jun P
    Cell Death Discov; 2024 Mar; 10(1):113. PubMed ID: 38443363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Diagnosis and Treatment Approach for Oligo-Recurrent and Oligo-Progressive Renal Cell Carcinoma.
    Bekku K; Kawada T; Sekito T; Yoshinaga K; Maruyama Y; Yamanoi T; Tominaga Y; Sadahira T; Katayama S; Iwata T; Nishimura S; Edamura K; Kobayashi T; Kobayashi Y; Araki M; Niibe Y
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated M2 macrophages in the immune microenvironment influence the progression of renal clear cell carcinoma by regulating M2 macrophage-associated genes.
    Zhang X; Sun Y; Ma Y; Gao C; Zhang Y; Yang X; Zhao X; Wang W; Wang L
    Front Oncol; 2023; 13():1157861. PubMed ID: 37361571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late recurrence of chromophobe renal cell carcinoma to unusual sites after 12 years of radical nephrectomy and radiotherapy: a rare case report from Syria.
    Zahlout J; Shmayyes H; Zahlout B; Salloum M; Kassab Y; Zahlouk N; Alshehabi Z
    Ann Med Surg (Lond); 2023 Apr; 85(4):1082-1087. PubMed ID: 37113924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
    Cosso F; Roviello G; Nesi G; Shabani S; Spatafora P; Villari D; Catalano M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report.
    Marra C; Losco L; Ceccaroni A; Pentangelo P; Troisi D; Alfano C
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676774
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
    Franzese C; Marini B; Baldaccini D; Badalamenti M; Navarria P; Bellu L; Franceschini D; Comito T; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Lo Faro L; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4411-4417. PubMed ID: 36109401
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.